Bossier City man dies after being found unresponsive in Shreveport lodge pool
According to the coroner's office, Michael McMillon, 61, was in the pool at the lodge in the 300 block of East Preston Avenue with family members when EMS was dispatched because McMillon was unresponsive.
He was transported to WK Pierremont Health Center emergency room just before 1:30 p.m. and was pronounced dead at 2:24 p.m.
According to the coroner's office, the manner and cause of death is still pending autopsy and toxicology results.
More: Top 5 stories from the Shreveport Times this week: Louisiana snakes, rodents on traps at restaurants
Makenzie Boucher is a reporter with the Shreveport Times. Contact her at mboucher@gannett.com.
This article originally appeared on Shreveport Times: Bossier City man dies, found unresponsive in Shreveport Elks Lodge pool
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
Marcus Morris arrest: Brother Markieff confirms situation, agent claims issue stems from unpaid casino debt
NBA veteran Marcus Morris was arrested Sunday on a fraud charge, Broward County booking records confirmed. Morris, 35, was apparently arrested at an airport due to "insufficient funds check," per the arrest information. While Morris has not commented on the situation, his brother, Markieff, confirmed the arrest, but claimed the fraud charge was "crazy." "The wording is crazy," Markieff said. "Damn for that amount of money they'll embarrass you in the airport with your family. They got y'all really thinking bro did some fraud s***. They could have came to the crib for all that. When y'all hear the real story on this s*** man. All I can say is Lesson learned. Bro will tell y'all tomorrow. This weird shit gave me a headache. Can't stop nothin!" Morris' agent, Yony Noy issued a response to Markieff's tweet. Noy attempted to clarify the situation, saying Marcus' arrest has nothing to do with a fake check. Noy claimed Morris was arrested over an unpaid credit with a casino. Noy called the arrest "absolutely insanity." Noy's full statement read: "Just so everyone understands this is zero fraud here or whatever crap outlets have said regarding fake checks or whatever the hell. This is due to an outstanding marker with a casino. Apparently if you have over $1,200 they can issue a warrant for your arrest. Absolute insanity!" Morris, a 13-year NBA veteran, saw time with a number of teams during his playing career. He spent four of his 13 seasons with the Los Angeles Clippers and three with the Phoenix Suns. He also saw time with six other franchises as a player. His final season in the NBA came in 2023-24, when he saw time with the Philadelphia 76ers and Cleveland Cavaliers. Morris appeared as a guest NBA analyst on ESPN during the offseason.
Yahoo
8 minutes ago
- Yahoo
ATAI Life Sciences (ATAI) Stock Plunge on Trial Failure News
July 28 - Atai Life Sciences (NASDAQ:ATAI) shares slid 9% in pre?market trading on Monday after Recognify Life Sciences, an Atai?backed company, reported its Phase 2b trial of inidascamine for cognitive impairment linked to schizophrenia missed its primary endpoint. Warning! GuruFocus has detected 6 Warning Signs with ATAI. The oral compound, engineered to modulate multiple neurotransmitter pathways for pro?cognitive effects, failed to outperform placebo on key cognitive measures. Recognify said the results fell short of statistical significance. Atai's CEO acknowledged the setback but highlighted inidascamine's potential in CIAS and other indications. He added that Atai will redirect its efforts toward its wholly?owned psychedelic programs focused on affective disorders. Investors have been closely watching Atai's broader pipeline, which includes compounds targeting depression, PTSD and Alzheimer's disease. This latest trial disappointment adds to a string of mid?stage readouts that have tested market sentiment around biotech firms pivoting to next?generation neuroscience therapies. Despite today's drop, Atai's management reiterated its commitment to advancing its lead psychedelic candidates through upcoming Phase 1 and Phase 2 trials. Based on the one year price targets offered by 6 analysts, the average target price for ATAI Life Sciences NV is $9.83 with a high estimate of $12.00 and a low estimate of $7.00. The average target implies a upside of +175.44% from the current price of $3.57. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
8 minutes ago
- Yahoo
Parents call on FDA for path forward after Duchenne's gene therapy pause
The Food and Drug Administration has paused distribution of the gene therapy Elevidys following the death of a third patient receiving treatment for muscular dystrophy. Alison and William Small are urging the agency to restore access to the drug, the only FDA-approved treatment for Duchenne's muscular dystrophy. Speaking to 'Morning in America,' the Smalls call for transparency and a clear path forward from federal regulators. They say families affected by Duchenne's deserve to understand the risks and that many believe the treatment is worth fighting for. Solve the daily Crossword
